Edition:
United States

Infinity Pharmaceuticals Inc (INFI.OQ)

INFI.OQ on NASDAQ Stock Exchange Global Select Market

2.03USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.03
Open
$2.03
Day's High
$2.05
Day's Low
$1.97
Volume
38,501
Avg. Vol
118,561
52-wk High
$3.75
52-wk Low
$0.93

Select another date:

Tue, May 8 2018

BRIEF-Infinity Pharmaceuticals Q1 Loss Per Share $0.18

* Q1 EARNINGS PER SHARE VIEW $-0.18 -- THOMSON REUTERS I/B/E/S

BRIEF-Infinity Pharmaceuticals Q1 Loss Per Share $0.18

* INFINITY PHARMACEUTICALS SAYS FOR THREE MONTHS ENDED MARCH 31, 2018, DILUTED LOSS PER COMMON SHARE WAS $0.18 - SEC FILING

BRIEF-Infinity Pharmaceuticals Files Prospectus Relates To Resale Of Up To 1.1 Mln Shares Of Co's Common Stock - SEC Filing

* INFINITY PHARMACEUTICALS INC FILES PROSPECTUS RELATES TO RESALE OF UP TO 1.1 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDER - SEC FILING Source text: (https://bit.ly/2HF2NcI) Further company coverage:

BRIEF-BVF Partners Reports 21.7 Pct Stake In Infinity Pharmaceuticals As Of April 10

* BVF PARTNERS LP REPORTS 21.7 PCT STAKE IN INFINITY PHARMACEUTICALS INC AS OF APRIL 10 - SEC FILING

BRIEF-Infinity Pharma Qtrly Diluted Loss Per Common Share $0.14​

* INFINITY PHARMACEUTICALS PROVIDES COMPANY UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Infinity Expects Net Loss For 2018 To Range From $40 Mln To $50 Mln​

* INFINITY PHARMACEUTICALS INC - ‍INFINITY EXPECTS NET LOSS FOR 2018 TO RANGE FROM $40 MILLION TO $50 MILLION​

Select another date: